Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma

NCT06562673 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma
Bone Cancer

Interventions

DRUG: intra-arterial cisplatin plus anti-angiogenesis inhibitor rh-endostatin (Endostar)

Sponsor

Shanghai 6th People's Hospital